Biomerics

Executive Summary

Biomerics is a vertically integrated contract manufacturer for interventional medical devices, serving cardiovascular, robotics, and endoscopy markets. Founded in 1997 and headquartered in Salt Lake City, the company offers end-to-end services from polymer compounding to finished device assembly across 12 global facilities. Its vertical integration enables cost efficiencies and quality control, positioning it as a key partner for OEMs seeking to accelerate time-to-market. With the increasing adoption of minimally invasive procedures, Biomerics is well-placed to benefit from rising demand for specialized components and assemblies. The company's private status and lack of disclosed financials suggest a focus on operational growth and strategic partnerships rather than public market pressures. Upcoming catalysts may include capacity expansions at existing facilities to meet growing demand, particularly in the cardiovascular segment, and potential new long-term supply agreements with major medical device firms. Additionally, Biomerics may benefit from regulatory approvals of client devices that rely on its components, though this is indirect. Given its established presence and market trends, the company is positioned for steady growth, though limited public information constrains conviction.

Upcoming Catalysts (preview)

• Q3 2026Capacity Expansion at Key Facilities70% success
• Q4 2026New Multi-Year Supply Agreement with Major OEM60% success
• Q2 2027Client Device FDA Approval Driving Component Demand50% success